Jafari · Phytotherapy research : PTR 2024 · systematic review and meta-analysis of randomized controlled trials · n=7216 participants (103 RCTs)

Curcumin on Human Health: A Comprehensive Systematic Review and Meta-Analysis of 103 Randomized Controlled Trials.

Cited 26 times in the scientific literature.

Level 1 - systematic review of randomized trials

Systematic review and meta-analysis of randomized controlled trials

PubMed 39478418 · doi:10.1002/ptr.8340 · record verified 2026-08-29

What was done

Authors conducted a systematic review and random-effects meta-analysis of randomized controlled trials (RCTs) indexed in PubMed, EMBASE, Scopus, and Web of Science from inception through September 2023. Studies comparing Curcuma longa L. (curcumin) against placebo for various health outcomes were included. Methodological quality was evaluated with the Newcastle-Ottawa Scale and evidence certainty was graded using the GRADE framework.

What was found

Across 103 RCTs with 7,216 total participants evaluating 42 outcomes, 23 outcomes (55%) showed statistically significant effect sizes (no numerical effect estimates, point differences, or confidence intervals were reported in the abstract). Evidence certainty was rated high for 4 outcomes (fasting blood sugar, C-reactive protein, high-density lipoprotein, and body weight), moderate for 10 outcomes (waist circumference, hip circumference, body mass index, insulin, HOMA-IR, QUICKI, leptin, gamma-glutamyl transferase, glutathione, and superoxide dismutase), low for 14 outcomes, and very low for 14 outcomes.

Why it matters

This review synthesizes a large body of clinical trials and indicates that curcumin supplementation reliably influences specific glycemic, lipid, inflammatory, and oxidative biomarkers.

Limits

The abstract provides no effect sizes, baseline values, or confidence intervals. Specific participant health statuses, curcumin dosages, formulations, and intervention durations are not reported. Additionally, the authors note overall methodological limitations across the included trials, and two-thirds of outcomes had low or very low certainty of evidence.

Cited by